- PRESS RELEASE: AFSIC – Investing in Africa
- Expert Opinion: Trump 2.0 Impact on Emerging Markets?
- Leveraging Digital Marketing to Boost Financial Sector Growth in Africa
- AFSIC Super Early Bird Rate Open - Save up to £1,440pp by Registering Now
- Countdown to Trump inauguration – what next for equities, interest rates oil, gold and bonds
French Drugs Maker Targets Africa With Nigerian Acquisition
LAGOS (Capital Markets in Africa) – Biogaran SAS, a closely held French pharmaceuticals manufacturer, plans to tap into Nigeria’s $1.3 billion drugs market as a launchpad for its expansion into Africa, company President Pascal Briere said. The unit of France’s second-largest drug maker, Les Laboratoires Servier, last month acquired Nigeria’s Swipha Limited. after an initial $500,000 investment. Biogaran expects Nigeria’s pharmaceuticals industry to grow by more than 12 percent annually. “We found that Nigeria is well adapted for what we…
Read More